The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat

Magnetic Resonance Imaging

Volumn 14, Issue 3, 1996, Pages 243-253

  Shuter, B ^a   Tofts, P S ^b   Wang, S C ^a   Pope, J M ^c  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Gd DTPA; Gd EOB DTPA; In vivo; Kidney; Liver; Relaxivity; T1; T2; Wistar rats

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HEPATOGRAPHY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RENOGRAPHY;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030003119     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0730-725X(95)02097-D     Document Type: Article

References (26)

1. Wolf, G.L. Current status of MR imaging contrast agents: Special report. Radiology 172:709-710; 1989.
2. Society for Magnetic Resonance in Medicine Workshop on Contrast Enhanced Magnetic Resonance. Napa, CA, May 23-25 1991. Magn. Reson. Med. 22:177-378; 1991.
3. Special focus issue: Contrast agents. JMRI 4:233-505; 1994.
4. Koutcher, J.A.; Burt, C.T.; Lauffer, R.B.; Brady, T.J. Contrast agents and spectroscopic probes in NMR. J. Nucl. Med. 25:506-513; 1984.
5. Lauffer, R.B. Paramagnetic complexes as water proton relaxation agents for NMR imaging : Theory and design. Chem. Rev. 87:901-927; 1987.
6. Weinmann, H.-J.; Brasch, R.C.; Press, W.-R.; Wesbey, G.E. Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. Am. J. Roentgenol. 142:619-624; 1984.
7. Unger, B.C.; Ugurbil, K.; Latchaw, R.E. Contrast agents for cerebral perfusion MR imaging. JMRI 4:235-242; 1994.
8. Mitchell, M.D.; Kundell, H.L.; Axel, L.A.; Joseph, P.M. Agarose as a tissue equivalent phantom material for NMR imaging. Magn. Reson. Imaging 4:263-266; 1986.
9. Schneiders, N.J. Solutions of two paramagnetic ions for use in nuclear magnetic resonance phantoms. Med. Phys. 15:12-16; 1988.
10. Mendelson, D.A.; Heinsbergen, J.F.; Kennedy, S.D.; Szczepaniak, L.S.; Lester, C.C.; Bryant, R.G. Comparison of agarose and cross-linked protein gels as magnetic resonance imaging phantoms. Magn. Reson. Imaging 9:975-978; 1991.
11. Tweedle, M.F.; Gaughan, G.T.; Hagan, J.; Wedeking, P.W.; Sibley, P.; Wilson, L.J.; Lee, D.W. Considerations involving paramagnetic coordination compounds as useful NMR contrast agents. Nucl. Med. Biol. 15:31-36; 1988.
12. Wedeking, P.; Sotak, C.H.; Telser, J.; Kumar, K.; Chang, C.A.; Tweedle, M.F. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn. Reson. Imaging 10:97-108; 1992.
13. Schuhmann-Giampieri, G.; Schmitt-Willich, H.; Press, W.-R.; Negishi, C.; Weinmann, H.-J.; Speck, U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59-64; 1992.
14. Pope, J.M.; Tofts, P.S.; Shuter, B.; Kron, T.; Wang, S. The use of MR image enhancement to measure Gd-DTPA concentration, in vivo relaxivity and blood-brain barrier leakage. In: Book of abstracts: Tenth Annual Meeting of the Society of Magnetic Resonance in Medicine. San Francisco, CA: SMRM; 1991:508.
15. 2* in liver, kidney and brain of the wistar rat. Magn. Reson. Imaging 13:563-574; 1995.
16. Ross, D.A.; Harris, C.C. Measurement of radioactivity. In: H.J. Wagner (Ed.). Principles of Nuclear Medicine. Philadelphia: W.B. Saunders Company; 1968: p. 136.
17. 2 and proton density analysis. Signa Echo Times 1:1-8; 1985.
18. Tofts, P.S.; Shuter, B., Pope, J.M. Ni-DTPA doped agarose gel - A phantom material for Gd-DTPA enhancement measurements. Magn. Reson. Imaging 11:125-133; 1993.
19. Tweedle, M.F.; Hagan, J.J.; Kumar, K.; Mantha, S.; Chang, C.A. Reaction of gadolinium chelates with endogenously available ions. Magn. Reson. Imaging 9:409-415; 1991.
20. Foster, M.A; Hutchison, J.M.S. Practical NMR Imaging. Oxford: IRL Press; 1987: p. 40.
21. 1. In: Book of Abstracts: Fourth Annual Meeting of the Society for Magnetic Resonance in Medicine. London: SMRM; 1985:904-905.
22. Endre, Z.H. Nuclear magnetic resonance and the kidney: Problems, solutions and future directions in renal NMR spectroscopy. In: K. Solez, L.C. Racusen (Eds.). Acute Renal Failure. New York: Marcel Dekker; 1991: pp. 247-271.
23. Ganong, W.F. Review of Medical Physiology. (17th Ed). Norwalk: Appleton & Lange; 1995: pp. 655-657.
24. Kennan, R.P.; Zhong, J.; Gore, J.C. On the relative importance of paramagnetic relaxation and diffusion mediated susceptibility losses in tissues. Magn. Reson. Med. 22:197-203; 1991.
25. Kennan, R.P.; Gao, J.-H.; Zhong, J.; Gore, J.C. General description of signal loss due to perfusion. In: Book of Abstracts: Eleventh Annual Meeting of the Society for Magnetic Resonance in Medicine. Berlin: SMRM; 1992:712.
26. Wolf, G.L.; Hoop, B.; Cannillo, J.A.; Rogowska, J.A.; Halpern, E.F. Measurement of renal transit of gadopentetate dimeglumine with echo-planar MR imaging. JMRI 4:365-372; 1994.